Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 873Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Hybrid approaches to clinical trial monitoring: Practical alternatives to 100% source data verification

De Sourabh

Year : 2011| Volume: 2| Issue : 3 | Page no: 100-104

   This article has been cited by
1 Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan
Tomohisa Sudo,Akihiro Sato
Therapeutic Innovation & Regulatory Science. 2017; 51(5): 589
[Pubmed]  [Google Scholar] [DOI]
2 The impact of clinical trial monitoring approaches on data integrity and cost—a review of current literature
Rasmus Olsen,Asger Reinstrup Bihlet,Faidra Kalakou,Jeppe Ragnar Andersen
European Journal of Clinical Pharmacology. 2016;
[Pubmed]  [Google Scholar] [DOI]
3 Data-driven risk identification in phase III clinical trials using central statistical monitoring
Catherine Timmermans,David Venet,Tomasz Burzykowski
International Journal of Clinical Oncology. 2016; 21(1): 38
[Pubmed]  [Google Scholar] [DOI]
4 Efficient Source Data Verification Using Statistical Acceptance Sampling
Rutger M. van den Bor,Bas J. Oosterman,Martinus B. Oostendorp,Diederick E. Grobbee,Kit C. B. Roes
Therapeutic Innovation & Regulatory Science. 2016; 50(1): 82
[Pubmed]  [Google Scholar] [DOI]
5 Evolving quality standards for large-scale registries: the GARFIELD-AF experience
Keith A.A. Fox,Bernard J. Gersh,Sory Traore,A. John Camm,Gloria Kayani,Anders Krogh,Shweta Shweta,Ajay K. Kakkar
European Heart Journal - Quality of Care and Clinical Outcomes. 2016; : qcw058
[Pubmed]  [Google Scholar] [DOI]
6 A Data-Driven Approach to Risk-Based Source Data Verification
Elizabeth Nielsen,DeAnn Hyder,Chao Deng
Therapeutic Innovation & Regulatory Science. 2014; 48(2): 173
[Pubmed]  [Google Scholar] [DOI]
7 Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials
Nicole Sheetz,Brett Wilson,Joanne Benedict,Esther Huffman,Andy Lawton,Mark Travers,Patrick Nadolny,Stephen Young,Kyle Given,Lawrence Florin
Therapeutic Innovation & Regulatory Science. 2014; 48(6): 671
[Pubmed]  [Google Scholar] [DOI]
8 Key Considerations in the Transition to Risk-Based Monitoring
Michael J. Rosenberg
Therapeutic Innovation & Regulatory Science. 2014; 48(4): 428
[Pubmed]  [Google Scholar] [DOI]
9 Taking the 'Risk' out of risk-based monitoring
Ashwaria Gupta
Perspectives in Clinical Research. 2013; 4(4): 193
[Pubmed]  [Google Scholar] [DOI]


Read this article